Top compounds associated with response to GMPR


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA ML083 CTRPv2 pan-cancer AAC -0.086 0.03
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.092 0.03
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC -0.12 0.03
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.078 0.03
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC -0.076 0.03
mRNA etoposide GDSC1000 pan-cancer AAC -0.078 0.03
mRNA ABT-263 FIMM pan-cancer AAC 0.3 0.03
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.081 0.03
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.03
Download CSV